Jun Yong Park

Research interests

Publications

• A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

  Journal of Hepatology · 2023 · https://doi.org/10.1016/j.jhep.2023.05.013

• Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma

  Journal of Hepatology · 2015 · https://doi.org/10.1016/j.jhep.2015.01.022

• Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011)

  Hepatology · 2015 · https://doi.org/10.1002/hep.28376

• Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis

  PLoS ONE · 2012 · https://doi.org/10.1371/journal.pone.0044930

• Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients

  Liver International · 2010 · https://doi.org/10.1111/j.1478-3231.2009.02192.x

• Risk Assessment of Hepatitis B Virus–Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan) σ

  Hepatology · 2010 · https://doi.org/10.1002/hep.24121

• A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis

  The American Journal of Gastroenterology · 2010 · https://doi.org/10.1038/ajg.2009.750

Current projects

No projects listed.